Intellia Therapeutics Inc (NTLA) Business News Oct. 27, 2025, 11:30 UTC Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z) Full text
There are no comments here yet...